Yutong Liu is a BCG consultant with heavy experience in biopharma R&D and commercial strategy. Her Recent projects include enterprise strategy and partnership strategy for top biopharma companies, growth strategy for mid-sized biotech, and digital strategy for clinical trials and R&D. She completed Harvard Bioengineering PhD, with a focus on cancer immunotherapy, biomaterials, and cell & gene therapy.